IP Library Granted Patent US 10,717,964
Granted Patent B2
US 10,717,964 · App. 16/042,257 · Granted Jul 21, 2020

Synthetic methylotrophy to liquid fuels and chemicals

Inventors: Eleftherios T. Papoutsakis (Newark, DE); Sergios Nicolaou (Larnaca, CY); Alan Fast (Newark, DE); Vasiliki Falara (Newark, DE); Robert Kyle Bennett (Elkton, MD); William Brian Whitaker (Newark, DE); Nicholas Richard Sandoval (Newark, DE); Jacqueline Gonzalez (Elkton, MD); Maciek Antoniewicz (Baltimore, MD)
Assignee: University of Delaware
C12N1/32C12N9/0006C12N9/88C12N9/90C12N15/52C12N15/70C12P7/16C12P7/40C12P7/42C12P7/44C12P7/46C12P7/625Y02E50/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,717,964
App. No.
16/042,257
Granted
Jul 21, 2020
Kind
B2
Abstract

A non-naturally occurring microbe capable of growing in a medium comprising methanol is provided. The methanol contributes to a significant percentage (e.g., at least 40%) of the carbon source for the non-naturally occurring microbe, which expresses heterologous methanol dehydrogenase (MDH) and heterologous ribulose monophosphate (RuMP) pathway enzymes. Methods for producing liquid fuels and chemicals by the non-naturally occurring microbe and methods for preparing the non-naturally occurring microbe are also provided.

Claims (19)

1. A method for producing a metabolite, comprising growing a non-naturally occurring microbe in a medium comprising methanol, wherein the non-naturally occurring microbe expresses heterologous methanol dehydrogenase (MDH) and one or more heterologous ribulose monophosphate (RuMP) pathway enzymes, wherein the heterologous MDH is Bacillus stearothermophilus MDH, wherein the one or more heterologous RuMP pathway enzymes comprise Bacillus methanolicus 3-hexulose-6-phosphate synthase (HPS) and Bacillus methanolicus 3-hexulose-6-phosphate isomerase (PHI), wherein the non-naturally occurring microbe is derived from Escherichia or Corynebacterium , and wherein the methanol contributes to at least 40% of the carbon source for the non-naturally occurring microbe, whereby the metabolite is produced.

2. The method of claim 1 , wherein the metabolite is selected from the group consisting of 4-carbon chemicals, diacids, 3-carbon chemicals, higher carboxylic acids, alcohols of higher carboxylic acids, and polyhydroxyalkanoates.

3. The method of claim 1 , wherein the metabolite is n-butanol.

4. The method of claim 1 , further comprising modifying the gene of heterologous MDH or any one of the one or more heterologous RuMP pathway enzymes, whereby the yield of the metabolite is improved.

5. The method of claim 1 , further comprising fixing CO 2 .

6. The method of claim 1 , wherein the non-naturally occurring microbe is grown at a temperature higher than 37° C.

7. The method of claim 1 , wherein the non-naturally occurring microbe is grown anaerobically.

8. The method of claim 1 , whereby at least 40% of the carbon in the metabolite is derived from the methanol.

9. The method of claim 1 , wherein the metabolite is an amino acid or tricarboxylic acid (TCA) intermediate having a carbon at the fourth position derived from the methanol, wherein the TCA intermediates are selected from the group consisting of succinate, succinyl-CoA, alpha-ketoglutarate, isocitrate, citrate, oxaloacetate, malate and fumarate.

10. The method of claim 1 , further comprising producing a metabolite by the non-naturally occurring microbe, and incorporating carbon from methanol into the metabolite, wherein at least 40% of the carbon in the metabolite is derived from the methanol.

11. The method of claim 1 , wherein the non-naturally occurring microbe is derived from Escherichia.

12. The method of claim 1 , wherein the non-naturally occurring microbe contains a deletion of an frmRAB operon.

13. The method of claim 1 , wherein the non-naturally occurring microbe expresses one or more heterologous pentose-phosphate pathway (PPP) enzymes.

14. The method of claim 13 , wherein the one or more heterologous PPP enzymes consist of heterologous phosphofructokinase (PFK), heterologous fructose bisphosphate aldolase (FBA), heterologous transketolase (TKT), heterologous fructose/sedoheptulose biphosphatase (GLPX), heterologous transaldolase (TAL), heterologous ribose-5-phospate isomerase (RPI) and heterologous ribulose phosphate epimerase (RPE).

15. The method of claim 1 , wherein the non-naturally occurring microbe expresses one or more heterologous cyclic formaldehyde dissimilation enzymes.

16. The method of claim 15 , wherein the one or more heterologous cyclic formaldehyde dissimilation enzymes consist of heterologous glucose-6-phosphate isomerase (PGI), glucose-6-phosphate-1-dehydrogenase (ZWF), 6-phosphogluconolactonase (PGL), and 6-phosphogluconate dehydrogenase (GND).

17. The method of claim 1 , wherein the non-naturally occurring microbe expresses one or more heterologous CO 2 fixation pathway enzymes.

18. The method of claim 1 , wherein the non-naturally occurring microbe is derived from Corynebacterium.

19. The method of claim 1 , wherein the non-naturally occurring microbe is Corynebacterium glutamicum.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 20, 2022
From: UNIVERSITY OF DELAWARE
To: U.S. DEPARTMENT OF ENERGY
Reel/Frame 061477/0033 →
Continuity (7)
Continuation 15112364
Provisional Application 61928052 · Jan 16, 2014
Provisional Application 61979058 · Apr 14, 2014
Provisional Application 62023208 · Jul 11, 2014
Provisional Application 62061731 · Oct 9, 2014
Provisional Application 62091799 · Dec 15, 2014
Related Publication 20190048310A1 · Feb 14, 2019